FDA Cautioned Public Against These Two Eye-drops Products; Ezricare Artificial Tears and Delsam Pharma’s Artificial Tears Owned By Global Pharma -See Statement Issued.
An emerging urgent report available to our portal has it that the Foods and Drugs Authority, shortened as FDA has warned the public against two eye-drops products.
The said products, thus, Ezricare Artificial Tears and Delsam Pharma Artificial Tears are owned by Global Pharma.
According to the regulatory body, the aforementioned product contains pseudomonas aeruginosa, a drug-resistant bacteria that is suspected of being responsible for three patient fatalities and eight patients losing their vision.
“The Food and Drug Authority (FDA) is alerting the public about a recent major incidence of contamination of two brands of eyedrops, EZRICARE ARTIFICIAL TEARS AND DELSAM PHARMA’S ARTIFICIAL TEARS owned by Global Pharma. Global Pharma has since issued a voluntary recall of the products.
“The US Centre for Disease Control and Prevention (USCDC) has classified the incident as an outbreak. According to the USCDC, the eyedrops were found to contain the drug-resistant bacteria pseudomonas aeruginosa and is suspected to have led to three deaths and vision loss in eight patients,” a statement by the FDA said.
The statement further recommended anybody who had used the aforementioned goods and were experiencing negative effects to seek medical attention.
“The FDA advises the public who may be in possession of these drugs through other means to immediately stop using the recalled products and submit them to any of the FDA offices nationwide.
“Anyone who has used these recalled products and is experiencing any symptoms should contact a healthcare professional immediately.”